Technology
Health
Biotechnology
Trillium Therapeutics
$0.34369876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.3436
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0094 (-2.66%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell TRIL and other stocks, options, ETFs, and crypto commission-free!
About TRIL
Trillium Therapeutics Inc. Common Shares, also called Trillium Therapeutics, is a clinical stage immuno-oncology company, which engages in the development of therapies for the treatment of cancer. Read More Its pipeline is comprised of TTI-621, TTI-622, and TTI-2341(EGFR Inhibitor). The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.
CEO
—
Employees
60
Headquarters
Mississauga, Ontario
Founded
2004
Market Cap
9.23M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
220.95K
High Today
$0.366
Low Today
$0.342
Open Price
$0.3512
Volume
97.92K
52 Week High
$6.75
52 Week Low
$0.3003
Collections
Technology
Health
Biotechnology
Therapy
Medical
Cancer Prevention
2014 IPO
Canada
Price Paid on Robinhood
65% Lower
Right Now
52 Week Low
$0.3003
Average Price Paid
$0.9689
52 Week High
$6.75
TRIL Earnings
-$0.91
-$0.81
-$0.71
-$0.61
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 7, Pre-Market